+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Anti-Ischemic Agents Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Ischemic Agents Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
From
From
From
Cold Pain Therapy Market Report 2025 - Product Thumbnail Image

Cold Pain Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Cancer Immunotherapy Market 2024-2028 - Product Thumbnail Image

Cancer Immunotherapy Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
Global Liposome Drug Delivery Market Analysis 2021-2031 - Product Thumbnail Image

Global Liposome Drug Delivery Market Analysis 2021-2031

  • Report
  • May 2022
  • 225 Pages
  • Global
From
Injectable Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Injectable Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
From
From
Precision Medicine Market 2025-2029 - Product Thumbnail Image

Precision Medicine Market 2025-2029

  • Report
  • June 2025
  • 222 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Viral Inactivation Market Report 2025 - Product Thumbnail Image

Viral Inactivation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator